MENEGATTI, Enea
 Distribuzione geografica
Continente #
NA - Nord America 10.095
AS - Asia 5.731
EU - Europa 4.819
SA - Sud America 947
AF - Africa 105
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 4
Totale 21.712
Nazione #
US - Stati Uniti d'America 9.923
SG - Singapore 2.150
FI - Finlandia 2.055
CN - Cina 1.491
BR - Brasile 742
UA - Ucraina 673
VN - Vietnam 589
IT - Italia 501
HK - Hong Kong 477
DE - Germania 449
GB - Regno Unito 339
TR - Turchia 332
FR - Francia 223
SE - Svezia 188
JP - Giappone 154
IN - India 150
RU - Federazione Russa 134
BD - Bangladesh 98
MX - Messico 81
AR - Argentina 70
CA - Canada 63
IQ - Iraq 51
PL - Polonia 48
ZA - Sudafrica 42
CO - Colombia 40
AT - Austria 33
NL - Olanda 33
ID - Indonesia 32
PK - Pakistan 31
EC - Ecuador 29
ES - Italia 24
LT - Lituania 21
BE - Belgio 19
PH - Filippine 18
RO - Romania 18
CL - Cile 16
JO - Giordania 15
SA - Arabia Saudita 15
UZ - Uzbekistan 15
VE - Venezuela 15
MY - Malesia 14
TH - Thailandia 14
KR - Corea 13
MA - Marocco 13
IL - Israele 12
PY - Paraguay 11
CZ - Repubblica Ceca 10
NP - Nepal 10
PE - Perù 10
CH - Svizzera 9
GR - Grecia 8
IR - Iran 8
UY - Uruguay 8
AE - Emirati Arabi Uniti 7
DZ - Algeria 7
EG - Egitto 7
AU - Australia 6
AZ - Azerbaigian 6
BF - Burkina Faso 6
BO - Bolivia 6
ET - Etiopia 6
PT - Portogallo 6
AL - Albania 5
HU - Ungheria 5
KE - Kenya 5
KZ - Kazakistan 5
NZ - Nuova Zelanda 5
PA - Panama 5
DO - Repubblica Dominicana 4
GT - Guatemala 4
KW - Kuwait 4
TN - Tunisia 4
TW - Taiwan 4
BH - Bahrain 3
CR - Costa Rica 3
JM - Giamaica 3
MD - Moldavia 3
NG - Nigeria 3
OM - Oman 3
AM - Armenia 2
AO - Angola 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
GA - Gabon 2
GE - Georgia 2
HN - Honduras 2
LV - Lettonia 2
MK - Macedonia 2
NI - Nicaragua 2
RS - Serbia 2
SN - Senegal 2
SV - El Salvador 2
XK - ???statistics.table.value.countryCode.XK??? 2
YE - Yemen 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
BW - Botswana 1
BZ - Belize 1
DK - Danimarca 1
EU - Europa 1
Totale 21.698
Città #
Helsinki 1.905
Singapore 1.314
Woodbridge 979
Ashburn 962
Fairfield 782
Houston 726
Jacksonville 722
Chandler 565
Santa Clara 550
San Jose 547
Hong Kong 457
Ann Arbor 448
Beijing 408
Seattle 301
Wilmington 284
Cambridge 252
Ho Chi Minh City 214
Izmir 205
Nanjing 203
New York 163
Tokyo 147
Hanoi 141
Princeton 141
Los Angeles 133
Dallas 116
Boardman 114
Lauterbourg 111
San Diego 84
São Paulo 77
Munich 69
Shenyang 63
Milan 60
Mexico City 58
Nanchang 55
Shanghai 52
Hefei 49
Hebei 39
Tianjin 39
Changsha 37
Warsaw 37
Brooklyn 35
Jiaxing 33
Buffalo 32
Chicago 32
Dearborn 32
Rio de Janeiro 32
London 30
Jinan 29
Baghdad 28
Falkenstein 28
Ferrara 28
Montreal 26
Norwalk 26
Orem 26
Chennai 25
Denver 25
Frankfurt am Main 25
Rome 25
San Mateo 25
Johannesburg 24
Stockholm 24
Belo Horizonte 23
Mountain View 23
Vienna 23
Da Nang 21
Moscow 21
Poplar 21
Atlanta 20
Manchester 20
Redwood City 20
Falls Church 19
Kunming 19
Ningbo 19
Guangzhou 18
Haiphong 18
Brussels 17
Turku 17
Auburn Hills 16
Bengaluru 16
Mumbai 16
Ankara 15
Brasília 15
San Francisco 15
Tashkent 14
Amman 13
Medellín 13
Biên Hòa 12
Naples 12
Philadelphia 12
Verona 12
Zhengzhou 12
Amsterdam 11
Bangkok 11
Boston 11
Curitiba 11
Hangzhou 11
Indiana 11
Orange 11
Bogotá 10
Dhaka 10
Totale 14.808
Nome #
Microemulsions of retinoids and pharmaceutical compositions containing them 1.971
Studio di uno spray topico di sucralfato gel e cidofovir per la terapia antivirale di ovini 378
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity 243
Skin care: The innovative nanotechnology to improve the performance of delivery systems 243
Amphiphilic association systems for amphotericin B delivery 227
Bioadhesive sucralfate gel-based suspension containing cidofovir for spray treatment of viral infections in lamb and sheep 226
Clotrimazole Nanoparticle gel for mucosal administration. 220
Respiratory Drug Delivery 218
Biodegradable microparticles for sustained delivery of tetracycline to the periodontal pocket: Formulatory and drug release studies 218
Cellulose acetate butyrate-pH/thermosensitive polymer microcapsules containing aminated poly(vinyl alcohol) microspheres for oral administration of DNA 218
Cubosome dispersions as delivery systems for percutaneous administration of indomethacin 215
Amphiphilic association systems for Amphotericin B delivery 214
Ursodeoxycholic acid for oral administration: a formulatory study of a suspension. 210
A novel multicompartimental system based on aminated poly(vinyl alcohol) microspheres/succinoylated pullulan microspheres for oral delivery of anionic drugs 209
Brain Targeting of an Antiischemic Agent by Nasal Administration of Microparticles 205
Budesonide microparticles for the treatment of Crohn's disease 201
Nanoparticulate lipid dispersions for bromocriptine delivery: characterization and in vivo study 201
Non-phospholipid vesicles as carriers for peptides and proteins: production, characterization and stability studies 200
Formulation study for the antitumor drug camptothecin: liposomes, micellar solutions and a microemulsion 198
Characterization of low -molecular-mass trypsin isoinhibitors from oil-rape (Brassica napus var. oleifera) seed 197
Design and characterization of fenretinide containing organogels 197
Cationic lipid nanosystems as carriers for nucleic acids 197
Cationic liposomes as carriers for ocular administration of anti herpetic peptides 196
Microparticles as delivery systems for local delivery to the oral cavity. 195
Cellulose acetate butyrate microcapsules containing dextran ion-exchange resins as self-propelled drug release system 195
Characterisation of potential adenosine A1 receptor prodrugs of adenosine derivatives with antiischemic properties 193
Active substance controlled release device for sanitization of spaces susceptible of containing degenerative organic material 190
Influence of formulation and process parameters on pellet production by powder layering technique 190
Effects of phospholipid based formulations on in vitro and in vivo percutaneous absorption of methyl nicotinate 186
Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: a preliminary study as possible vaccine against genital herpes 185
Kinetics of bromocriptine release from microspheres: Comparative analysis between different in vitro models 181
Nanostructured lipid carriers as delivery systems for parkinson’s therapy 181
Eudragit® microparticles for the release of budesonide: A comparative study 181
Preparation of liposomes by reverse-phase evaporation using alternative organic solvents 180
Nanosystems for skin hydration: a comparative study 180
Ethosomes and liposomes as topical vehicles for azelaic acid: A preformulation study 176
Bioencapsulation methods for cell inclusion in polysaccharidic matrices for clinical applications 176
Liposome-associated retinoids: production, characterization and antiproliferative activity on neoplastic cells 175
Characterization of five new low-molecular-mass trypsin inhibitors from white mustard (Sinapis alba L.)seed 175
Alginate and cell combination product for wound healing 175
Cationic liposomes carrying anti herpetic peptides as potential ocular vaccine 174
Effect of cationic liposome composition on in vitro cytotoxicity and protective effect on carried DNA 174
In vitro cytotoxic activity of some glucosinolate-derived products generated by myrosinase hydrolysis 173
Cationic nanostructured lipid carrier (NLC) and monoolein aqueous dispersions (MAD) as potential carriers for nucleic acids 173
Preparation and characterisation of thermoresponsive poly [(N-isopropylacrylamide-co-acrylamide-co(hydroxyethyl acrylate)] microspheres as a matrix for the pulsed release of drugs 172
Lipid-based supramolecular systems for topical application: A preformulatory study 171
Myrosinase-generated isothiocyanate from glucosinolates: Isolation, characterization and in vitro antiproliferative studies 167
Effect of charge and lipid concentration on in-vivo percutaneous absorption of methyl nicotinate from liposomal vesicles 166
Combination of alginate and cells for skin regeneration 165
Properties and applications of liposomes in cosmetics 164
GELATIN MICROSPHERES AS A NEW APPROACH FOR THE CONTROLLED DELIVERY OF SYNTHETIC OLIGONUCLEOTIDES AND PCR-GENERATED DNA FRAGMENTS 164
Influence of liposomal formulation parameters on the in vitro absorption of methyl nicotinate 163
Eudragit® /Pluronic nanoparticles as mucosal delivery system for peptides and proteins: an in vitro study 163
Selective inhibition of human mast cell tryptase by gabexate mesylate, an antiproteinase drug 160
Development of polymethacrylic/poloxamer microparticles for topical administration of biotech drugs 160
Poly[(N-isopropylacrylamide-co-acrylamide-co-(hydroxyethylmethacrylate)]thermoresponsive microspheres: an accurate method based on solute exclusion technique to determine the volume phase transition temperature 158
Colloidal dispersions for the delivery of acyclovir: A comparative study 157
Cross-enzyme inhibition by gabexate mesylate: Formulation and reactivity study 156
In vitro antiproliferative activity of isothiocyanates and nitriles generated by myrosinase-mediated hydrolysis of glucosinolates from seeds of cruciferous vegetables 156
Preparation and characterisation of poly(vinyl alcohol)/cyclodextrin microspheres as matrix for inclusion and separation of drugs 156
Liposomes- and ethosomes-associated distamycins: a comparative study 155
Dextran cross-linked gelatin microspheres as a drug delivery system 155
Spray dried Eudragit microparticles as encapsulation devices for vitamin C 154
Production and characterization of biodegradable microparticles for the controlled delivery of proteinase inhibitors 154
Hyaluronan-based microspheres as tools for drug delivery: a comparative study 153
Nasal administration and brain targeting of an antiischemic agent 151
Preparation and characterization of cationic microspheres for gene delivery 151
Preparation and characterization of collagen sponges for dermo-cosmetic applications 150
Materie Prime: Eccipienti 147
N6-cyclopentyladenosine : selective brain targeting by nasal administration of microparticles 146
Ethosomes for the delivery of anti-HSV-1 molecules: preparation, characterization and in vitro activity. 146
Eudragit microparticles as a possible tool for ophthalmic administration of acyclovir 143
Peptide-based cationic liposomes and micelles as a new tool for nonviral gene delivery 143
Lecithin organogels as cosmetic formulations for methyl nicotinate 143
Production of pellet by powder layering technique: coating with acrylic polymers for enteric drug release 141
Preparation and characterization of starch/cyclodextrin bioadhesive microspheres as platform for nasal administration of Gabexate Mesylate (Foy (R)) in allergic rhinitis treatment 139
Solid Lipid Nanoparticles as Delivery Systems for Bromocriptine 139
Production and characterization of cubosome: a new tool for percutaneous administration of lipophilic drugs 138
Eudragit®/Pluronic nanoparticles for the administration of peptides and proteins 136
Innovative nanotechnology based systems for dermal application 135
Brain Uptake of an Antiischemic Agent by Nasal Administration of Microparticles 134
NEW DELIVERY SYSTEMS FOR RETINOIDS APPLICATION 133
DNA binding activity and inhibition of DNA-protein interactions. Differential effects of tetra-p-amidino-phenoxyneopentane and its 2′-bromo derivative 132
Ethosomes for the delivery of anti-herpetic molecules 131
Lipid-based dispersions for drug delivery 130
Diclofenamic acid-vitamin C conjugates: stability and interaction studies with ascorbate transporters 126
Eudragit/Pluronic microparticles for topical administration of peptides and proteins 123
Therapeutic paint for simultaneous delivery of sucralfate gel and cidofovir in the treatment of veterinary viral skin infections 120
Spray-drying production of trypsin-containing microparticles 120
Peptide-based molecules for the production of positive charged liposomes and micelles 119
Niosomes for vaginal administration of an antiherpetic peptide 118
In vitro comparison of four anti-inflammatory topical medications 116
Liposomes and micellar solutions for the delivery of some benzoheterocyclic derivatives of distamycin A 115
Spray drying production of trypsin containing microparticles 115
Semisolid formulations based on MAD or NLC for mucosal administration of Clotrimazole 115
Modulation of protease activity by NO-mediated S-nitrosylation. 115
Soft agglomerates containing microencapsulated levothyroxine for buccal or oral delivery 115
Oligonucleotide-carrying microspheres. Production, characterization and release characteristics 114
Production and antiproliferative activity of liposomes containing the antitumour drug chromomycin A(3) 114
null 113
Totale 18.545
Categoria #
all - tutte 86.751
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.404
Totale 91.155


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202182 0 0 0 0 0 0 0 0 0 0 0 82
2021/20221.252 43 153 114 79 41 52 64 77 36 95 125 373
2022/20231.302 151 48 32 164 221 224 25 130 170 8 88 41
2023/2024623 76 83 24 10 43 114 29 40 8 30 36 130
2024/20252.656 74 41 183 68 385 282 88 152 465 264 391 263
2025/20268.919 698 375 662 1.113 891 471 716 423 2.506 795 253 16
Totale 21.800